An introduction to MS-UK’s new Exercise Choices booklet and cognitive exercises

Featuring guest speaker Dr Dawn Langdon

Wednesday 17 May at 10am 

We are proud to announce the release of our revamped Choices booklet that focuses on exercise and multiple sclerosis (MS).  

This new version has been completely rewritten, with the aim of giving the reader and wider MS community more information about the benefits of exercise in managing the impact of MS. Also, for the first time in the history of our exercise-focused booklet, we include information about cognitive exercise and how it can be used to support brain health. 

To accompany the launch of our revised booklet we invite you to our forthcoming Exercise and MS workshop as part of our online activities program. This session will be formed of two parts.  

In part one Shaun Barton, a member of our helpline team, will take us through the booklet, with a summary of the purpose of each section, which includes a look at MS symptom-focused exercise and alternatives to traditional forms of exercise.  

For part two we are proud to be joined by Dr Dawn Langdon, Professor of Neuropsychology at the Royal Holloway, University of London. Dr Langdon will provide us with a background of Cognitive Rehabilitation Therapy (CRT), what it entails and how it can be used to help support people with MS. Dr Langdon will also share information about other ways in which we can bolster our cognitive pathways, such as lifestyle changes and challenging our brains, including essential tips and tricks which are accessible to those with different levels of ability and resources available.  

If you are unable to make the live session, don’t worry as we will be recording the presentation and will make it available to watch again for all those who have registered to our portal and have purchased a ticket for this workshop. 

How to book 

This session is free to join if you have a monthly or yearly subscription. You do not need a subscription to join, as you can register and provide a donation for the class. The suggested amount for the class is £5. If you are unable to make a donation, please contact us to see how you can access the online classes ( 

A recording will be made available after the class and can be viewed if you have purchased a ticket either before or after the class has taken place.  


Joining the class 

If you have purchased a ticket to join the class live, a blue button saying ‘Join class’ will appear at the bottom of the page 15 minutes before the class is due to start.  


Viewing the recording 

Shortly after the class has finished, the recording will be made available and a blue button will be visible at the bottom of the screen for everyone who purchases a ticket either in advance of the live class are after it has been held 

If you would like to know more or you are having trouble registering, please contact us at 


Dr Langdon is neuropsychology lead on a number of multinational trials for the pharmaceutical industry.More about Dr Dawn Langdon 

Dr Langdon completed her training as a clinical psychologist at Oxford University and the Institute of Psychiatry, KCL. She worked as a clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London for sixteen years, obtaining a PhD on reasoning in organic brain syndromes from the Institute of Neurology, UCL and registration as both a neuropsychologist and a health psychologist.  

Dr Langdon is Neuropsychology Lead on a number of multinational trials for the pharmaceutical industry. She has worked extensively on psychological aspects of MS, including measurement of cognition and its relation to pathology and other disease variables, also investigating how the risks and benefits of MS medication are best communicated to patients, including a successful randomised control trial comparing the new protocol to consultation as usual. Other interests are how employment relates to cognition in MS and how psychological variables influence adherence.  

She is Co-Chair of the BICAMS initiative (, which has recommended a brief cognition tool for MS. There are currently 36 countries in the national validation pipeline, of whom 24 have published. The AAN have recommended BICAMS as part of its Quality Measurement Set for MS. Over 30 peer review journal articles recommend BICAMS for routine assessment. BICAMS has been used in a number of international pharma trials and also in other investigations of MS cognition relating to imaging, employment and everyday life tasks; in total 100 scientific papers have reported BICAMS results.